FiercePharma: AbbVie launches new Skyrizi commercial after topping TV drug ad spenders’ ranking in July
AbbVie launches new Skyrizi commercial after topping TV drug ad spenders’ ranking in July
SKYRIZI is a biologic that has been prescribed to more than 260,000 patients in the USA. * * Includes adults with: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s disease, and Ulcerative Colitis. Data is sourced from Symphony Health, an ICON plc Company, IDV ® and SKYRIZI Bridge Program data from April 2019 through November 2024.
Learn about SKYRIZI® for adults with moderate to severe Crohn’s disease. See full Safety and Prescribing Information.
Discover SKYRIZI, an FDA-approved biologic treatment for psoriasis. See full Safety and Prescribing Information.
SKYRIZI (Sky-RIZZ-ee; skaɪ rɪz zi), an injection, is known as an interleukin-23 (IL-23) inhibitor. † It works inside your body to treat adults with moderate to severe Ps who can take injections, pills (systemic therapy), or ultraviolet light therapy (phototherapy), and for adults with active PsA. * A biologic is a type of medication that is derived from living organisms, such as cells ...
The SKYRIZI design SKYRIZI works with your immune system, attaching to a specific protein that can cause inflammation. By attaching to this protein, SKYRIZI helps reduce chronic inflammation inside your body that leads to painful, discolored, itchy, burning plaques on the skin.
See SKYRIZI® results for the treatment of psoriasis. SKYRIZI® is an FDA-approved biologic treatment for psoriasis See full Safety and Prescribing Information.
Find important SKYRIZI safety information & learn about the potential side effects of SKYRIZI treatment for Ps and PsA. See Full Safety & Prescribing Info.